151751-Najiba-Chargi

24 CHAPTER 1 28. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on defini- tion and diagnosis: Report of the Europe- an Working Group on Sarcopenia in Older People. Age Ageing . 2010;39(4):412-423. doi:10.1093/ageing/afq034 29. von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and num- bers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle . 2010;1(2):129- 133. doi:10.1007/s13539-010-0014-2 30. Bundred J, Kamarajah SK, Roberts KJ. Body composition assessment and sarco- penia in patients with pancreatic cancer: a systematic review and meta-analysis. HPB . 2019;21(12):1603-1612. doi:10.1016/j. hpb.2019.05.018 31. Kamarajah SK, Bundred J, Tan BHL. Body composition assessment and sarcopenia in patients with gastric cancer: a systematic review and meta-analysis. Gastric Cancer . 2019;22(1):10-22. doi:10.1007/s10120-018- 0882-2 32. Boshier PR, Heneghan R, Markar SR, Bara - cos VE, Low DE. Assessment of body com - position and sarcopenia in patients with esophageal cancer: A systematic reviewand meta-analysis. Dis Esophagus . 2018;31(8). doi:10.1093/dote/doy047 33. Yang M, Shen Y, Tan L, Li W. Prognostic Value of Sarcopenia in Lung Cancer: A Systematic Review and Meta-analysis. Chest . 2019;156(1):101-111. doi:10.1016/j. chest.2019.04.115 34. Mintziras I, Miligkos M, Wächter S, Manoha - ran J, Maurer E, Bartsch DK. Sarcopenia and sarcopenic obesity are significantly associ- ated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis. Int J Surg . 2018;59:19- 26. doi:10.1016/j.ijsu.2018.09.014 35. Hébuterne X, Lemarié E, Michallet M, de Montreuil CB, Schneider SM, Goldwasser F. Prevalence of Malnutrition and Current Use of NutritionSupport inPatientsWithCancer. J Parenter Enter Nutr . 2014;38(2):196-204. doi:10.1177/0148607113502674 36. Prado CMM, Heymsfield SB. Lean Tissue Im - aging. J Parenter Enter Nutr . 2014;38(8):940- 953. doi:10.1177/0148607114550189 37. Lee SY, Gallagher D. Assessment methods in human body composition. Curr Opin Clin Nutr Metab Care . 2008;11(5):566-572. doi:10.1097/MCO.0b013e32830b5f23 38. Shen W, Punyanitya M, Wang Z, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdom- inal cross-sectional image. J Appl Physiol . 2004;97(6):2333-2338. doi:10.1152/jap - plphysiol.00744.2004 39. B. Heymsfield S, Wang Z, Baumgartner RN, Ross R. Human Body Composition: Advanc - es in Models and Methods. Annu Rev Nutr . 1997;17(1):527-558. doi:10.1146/annurev. nutr.17.1.527 40. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sar- copenic obesity in patients with solid tu- mours of the respiratory and gastrointesti- nal tracts: a population-based study. Lancet Oncol . 2008;9(7):629-635. doi:10.1016/ S1470-2045(08)70153-0 41. Prado CMM, Baracos VE, McCargar LJ, et al. Sarcopenia as a Determinant of Che - motherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment. Clin Cancer Res . 2009;15(8):2920-2926. doi:10.1158/1078-0432.CCR-08-2242 42. van Vugt JLA, Buettner S, Levolger S, et al. Low skeletal muscle mass is associat - ed with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract. Bianchi C, ed. PLoS One . 2017;12(10):e0186547. doi:10.1371/journal. pone.0186547

RkJQdWJsaXNoZXIy ODAyMDc0